Here, patients with high PAI-2 mRNA expression levels showed a reduced risk of relapse, implying a better prognosis, whereas high uPAR mrNA expression correlated with a high risk of cancer recurrence, and the co-expression of both factors enriched prognostic determination from UICC staging information. Here, SERPINB2 is linked to cancer.